Medindia

X

Genomma Lab Announces the Successful Launch of the Ma Evans Brand

Friday, December 12, 2008 General News J E 4
Advertisement
MEXICO CITY, Dec. 11 Genomma Lab Internacional,S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), a leading Mexicanover-the-counter ("OTC") pharmaceuticals and personal care products companyannounced today the successful launch of the personal hair care product lineMa Evans. The product launch was realized through a mass media campaign underthe brand name "Ma Evans Evolution". The Company has been successful inplacing the product in the market through its distribution channels. Inaddition, the product has been well-received at the point of sale, and hassurpassed initial sales objectives. The product launch contains five SKU's inthe anti-hair loss shampoo, anti-hair loss treatment and hair gel categories.

The Ma Evans brand was acquired by Genomma Lab during the fourth quarter2007 due to its high level of brand recognition in the shampoo and anti-hairloss treatment categories. With this launch, Genomma Lab reinforces itspresence in the hair care category, in which it currently participates underthe anti-dandruff shampoo brand Medicasp. The market size of the Mexican haircare category is approximately Ps. 15 billion pesos(1).

With this launch, Genomma Lab confirms its capacity to acquire, transformand re-launch brands focused on the target consumer's likes and preferences.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counterpharmaceuticals and personal care products company in Mexico withinternational presence. Genomma develops, sells and markets a broad range ofpremium branded products, many of which are leaders in the categories in whichthey compete in terms of sales and market share.

Genomma Lab performed its Initial Public Offering in June, 2008, through acombined offering (mainly primary) and is listed on the Mexican Stock Exchangeunder the ticker symbol "LAB" (Bloomberg: labb.mx).Web Site: www.genommalab.com (1) Source: Nielsen (2007) Investor Relations Contact: Tel: +52 (55) 5081 0000 Ext. 4250 E-mail: inversion@genommalab.com In New York: i-advize Corporate Communications, Inc. Tel: (212) 406-3692 E-mail: genomma@i-advize.com

SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
St. John's Hospital Recognized by The Leapfrog Gro...
S
Rosalind Franklin University of Medicine and Scien...